Berlin –
The German High Commission on Vaccination indicates that juveniles are only recommended the vaccine against the coronavirus of the British laboratory AstraZeneca for people under 65 years of age, due to the lack of information about its effects in more than one year.
“The vaccine against AstraZeneca’s COVID-19 is currently recommended for people between 18 and 64 years old”, said the commission in a document consulted by the AFP, explaining that “the available data is currently available to evaluate the efficiency of the more than 65 years old vacancies”.
Under this exception, AstraZeneca’s vacancy, unveiled alongside the University of Oxford, is considered “as indicated” to protect against the COVID-19 as undeveloped by the BioNTech / Pfizer and Moderna laboratories, which are homologated by the Union Europe.
The information on the British vaccine must be examined by the European regulator, who must authorize it. Each Member State is free to issue its recommendations on the use of the vaccine.
The German Commission is committed to managing the holiday camps in the country. German media outlets have been able to reduce the AstraZeneca’s vaccine efficiency for the 65-year-olds.
These affirmations were made by the manufacturer and by the German governor, who claimed that the press had mixed dates.
Without embarrassment, AstraZeneca’s CEO, Pascal Soriot, acknowledged that it has “a limited amount of data on the” advanced “population” and “possible” that some countries prefer to manage this part of the population now.
According to AstraZeneca, the vacancy rate is 70% (compared to 90% of Pfizer / BioNTech and Modern), a result validated by the scientific review The Lancet.
Since then, the British Laboratory has been blatantly denouncing European leaders, debiting them at the entrances to the EU. (I)